Who makes CP-70,429 and PF-03709270?

CP-70,429 and PF-03709270 is developed by Pfizer.

What development phase is CP-70,429 and PF-03709270 in?

CP-70,429 and PF-03709270 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

CP-70,429 and PF-03709270

Pfizer · Phase 1 active Small molecule

At a glance

Generic name	CP-70,429 and PF-03709270
Also known as	CP-70,429 - sulopenem
Sponsor	Pfizer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CP-70,429 and PF-03709270 CI brief — competitive landscape report
CP-70,429 and PF-03709270 updates RSS · CI watch RSS
Pfizer portfolio CI